Venari Medical announces publication of pre-clinical data in

/PRNewswire/ -- InVera Medical are delighted to announce the publication of its pre-clinical feasibility study of the InVera minimally invasive, exclusively

Venari Medical - Products, Competitors, Financials, Employees, Headquarters Locations

Temasek Review 2015 - Embracing the Future

Speakers & Panelists — MedTech Strategist

RECONAFRICA ANNOUNCES NEW CHIEF EXECUTIVE OFFICER AND GENERAL COUNSEL

Earlybird Venture Capital on LinkedIn: #ebvchealth #ebvclive #tbchcambridge #techbio #startups #networking

Bridging clinical and real-world data

Irish medical and life sciences innovators

MindMaze to advance digital neurotherapeutics with $105-million raise - MedTech Innovator

Houma — News — Terrebonne Economic Development Authority

Ivera Medical - Crunchbase Company Profile & Funding

VUMC Research Resources Department of Orthopaedic Surgery

Nerviano Medical Sciences to Present Preliminary Phase 1 PARP1 selective inhibitor data at the 35th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Nerviano Medical Sciences

Safety and Diagnostic Efficacy of Gadobenate Dimeglumine in MRI of the Brain and Spine of Neonates and Infants

Vanuatu Security News, Vanuatu Security Company, Applications & Event News